Anja Meyer
Koeln, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Treatment of rheumatoid arthritis with baricitinib or upadacitinib is associated with reduced scaffold protein NEDD9 levels in CD4+ T cells.
Journal: Physiological reports
Published: May 18, 2023
Truncated isoforms of GPSM2 containing the GoLoco motif region promote CD4+ T-cell migration in SLE.
Truncated isoforms of GPSM2 containing the GoLoco motif region promote CD4+ T-cell migration in SLE.
Journal: Lupus science & medicine
Published: June 02, 2022
Regulatory T Cells from Patients with Rheumatoid Arthritis Are Characterized by Reduced Expression of Ikaros Zinc Finger Transcription Factors.
Journal: Cells
Published: May 18, 2022
Membrane-bound IL-6R is upregulated on Th17 cells and inhibits Treg cell migration by regulating post-translational modification of VASP in autoimmune arthritis.
Journal: Cellular and molecular life sciences : CMLS
Published: August 09, 2021
Kinase activity profiling reveals contribution of G-protein signaling modulator 2 deficiency to impaired regulatory T cell migration in rheumatoid arthritis.
Journal: Journal of autoimmunity
Published: May 29, 2021
Cannabinoids drive Th17 cell differentiation in patients with rheumatic autoimmune diseases.
Journal: Cellular & molecular immunology
Published: March 28, 2020
Regulatory T cell frequencies in patients with rheumatoid arthritis are increased by conventional and biological DMARDs but not by JAK inhibitors.
Journal: Annals of the rheumatic diseases
Published: November 01, 2019
Prostaglandin receptor EP4 expression by Th17 cells is associated with high disease activity in ankylosing spondylitis.
Journal: Arthritis research & therapy
Published: December 12, 2018
Failure of a T cell regulator: CD6 contributes to the aggravation of autoimmune inflammation.
Journal: Cellular & molecular immunology
Published: June 12, 2018
Showing 1-9 of 9
Last Updated: 09/26/2026